SI0901470T1 - Indole derivatives useful as endothelin receptor antagonists - Google Patents

Indole derivatives useful as endothelin receptor antagonists

Info

Publication number
SI0901470T1
SI0901470T1 SI9730646T SI9730646T SI0901470T1 SI 0901470 T1 SI0901470 T1 SI 0901470T1 SI 9730646 T SI9730646 T SI 9730646T SI 9730646 T SI9730646 T SI 9730646T SI 0901470 T1 SI0901470 T1 SI 0901470T1
Authority
SI
Slovenia
Prior art keywords
receptor antagonists
indole derivatives
endothelin receptor
derivatives useful
useful
Prior art date
Application number
SI9730646T
Other languages
English (en)
Slovenian (sl)
Inventor
David James Rawson
Kevin Neil Dack
Roger Peter Dickinson
Kim James
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of SI0901470T1 publication Critical patent/SI0901470T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
SI9730646T 1996-05-09 1997-04-11 Indole derivatives useful as endothelin receptor antagonists SI0901470T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9609641.7A GB9609641D0 (en) 1996-05-09 1996-05-09 Compounds useful in therapy
PCT/EP1997/001882 WO1997043260A1 (en) 1996-05-09 1997-04-11 Indole derivatives useful as endothelin receptor antagonists
EP97920690A EP0901470B1 (en) 1996-05-09 1997-04-11 Indole derivatives useful as endothelin receptor antagonists

Publications (1)

Publication Number Publication Date
SI0901470T1 true SI0901470T1 (en) 2004-08-31

Family

ID=10793387

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730646T SI0901470T1 (en) 1996-05-09 1997-04-11 Indole derivatives useful as endothelin receptor antagonists

Country Status (42)

Country Link
US (4) US6017945A (cs)
EP (1) EP0901470B1 (cs)
JP (1) JP3245179B2 (cs)
KR (1) KR100331217B1 (cs)
CN (1) CN1124262C (cs)
AP (1) AP830A (cs)
AR (1) AR007030A1 (cs)
AT (1) ATE263151T1 (cs)
AU (1) AU717849B2 (cs)
BG (1) BG102873A (cs)
BR (1) BR9709072A (cs)
CA (1) CA2253876A1 (cs)
CO (1) CO4650036A1 (cs)
CZ (1) CZ292928B6 (cs)
DE (1) DE69728392T2 (cs)
DK (1) DK0901470T3 (cs)
DZ (1) DZ2227A1 (cs)
EA (1) EA001471B1 (cs)
ES (1) ES2218675T3 (cs)
GB (1) GB9609641D0 (cs)
HN (1) HN1997000058A (cs)
HR (1) HRP970249B1 (cs)
HU (1) HUP9901245A3 (cs)
ID (1) ID16878A (cs)
IL (1) IL125903A0 (cs)
IS (1) IS1856B (cs)
MA (1) MA26428A1 (cs)
NO (1) NO312547B1 (cs)
NZ (1) NZ332640A (cs)
OA (1) OA10896A (cs)
PE (1) PE65098A1 (cs)
PL (1) PL329725A1 (cs)
PT (1) PT901470E (cs)
SI (1) SI0901470T1 (cs)
SK (1) SK150398A3 (cs)
TN (1) TNSN97078A1 (cs)
TR (1) TR199802269T2 (cs)
TW (1) TW491838B (cs)
UA (1) UA50767C2 (cs)
UY (1) UY24546A1 (cs)
WO (1) WO1997043260A1 (cs)
ZA (1) ZA973963B (cs)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9722287D0 (en) 1997-10-22 1997-12-17 Pfizer Ltd Compounds useful in therapy
DK1154774T3 (da) 1999-02-10 2005-09-26 Astrazeneca Ab Quinazolinderivater som angiogenesisinhibitorer
GB0016162D0 (en) * 2000-06-30 2000-08-23 Cancer Res Campaign Tech Indole-3-acetic acid derivatives
US20050203166A1 (en) * 2000-06-30 2005-09-15 Cancer Research Technology Limited Indole-3-acetic acid derivatives
WO2003000253A1 (en) 2001-06-20 2003-01-03 Wyeth Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
TWI224101B (en) 2001-06-20 2004-11-21 Wyeth Corp Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
MXPA05006287A (es) 2002-12-10 2005-09-08 Wyeth Corp Derivados de acido indoloxo-acetilaminoacetico sustituidos como inhibidores del inhibidor del activador de plasminogeno 1 (pai-1).
UA80453C2 (en) 2002-12-10 2007-09-25 Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
ATE411288T1 (de) 2002-12-10 2008-10-15 Wyeth Corp Aryl-, aryloxy- und alkyloxysubstituierte 1h- indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1)
MXPA05006282A (es) 2002-12-10 2005-08-19 Wyeth Corp Derivados del acido 1h-indol-1-il acetico de 3-alquilo y 3-arilalquilo sustituido como inhibidores del inhibidor-1 de activador de plasminogeno (pai-1).
AU2003297787A1 (en) 2002-12-10 2004-06-30 Wyeth Substituted 3-carbonyl-1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
MXPA05007857A (es) * 2003-01-22 2005-10-18 Lilly Co Eli Moduladores derivados de indol de receptores nucleares de hormonas esteroideas.
US7141592B2 (en) 2003-09-25 2006-11-28 Wyeth Substituted oxadiazolidinediones
US7351726B2 (en) 2003-09-25 2008-04-01 Wyeth Substituted oxadiazolidinediones
US7332521B2 (en) 2003-09-25 2008-02-19 Wyeth Substituted indoles
US7268159B2 (en) 2003-09-25 2007-09-11 Wyeth Substituted indoles
US7534894B2 (en) 2003-09-25 2009-05-19 Wyeth Biphenyloxy-acids
US7163954B2 (en) 2003-09-25 2007-01-16 Wyeth Substituted naphthyl benzothiophene acids
US7342039B2 (en) 2003-09-25 2008-03-11 Wyeth Substituted indole oximes
US7446201B2 (en) 2003-09-25 2008-11-04 Wyeth Substituted heteroaryl benzofuran acids
US7442805B2 (en) 2003-09-25 2008-10-28 Wyeth Substituted sulfonamide-indoles
US7265148B2 (en) 2003-09-25 2007-09-04 Wyeth Substituted pyrrole-indoles
US7411083B2 (en) 2003-09-25 2008-08-12 Wyeth Substituted acetic acid derivatives
US7420083B2 (en) 2003-09-25 2008-09-02 Wyeth Substituted aryloximes
US7582773B2 (en) 2003-09-25 2009-09-01 Wyeth Substituted phenyl indoles
JP2005109006A (ja) * 2003-09-29 2005-04-21 Tdk Corp 高電圧貫通型コンデンサ及びマグネトロン
HN2004000536A (es) 2003-12-16 2009-02-18 Wyeth Corp Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles
RU2007106868A (ru) 2004-08-23 2008-09-27 Вайет (Us) Оксазол-нафтиловые кислоты и их применение в качестве модуляторов ингибитора активатора плазминогена-1 (pai) для лечения тромбоза и сердечно-сосудистых заболеваний
BRPI0514549A (pt) 2004-08-23 2008-06-17 Wyeth Corp ácidos de pirrol-naftila como inibidores de pai-1
WO2006023866A2 (en) 2004-08-23 2006-03-02 Wyeth Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1
CA2617372A1 (en) 2005-08-17 2007-02-22 Wyeth Substituted indoles and use thereof
US20100022568A1 (en) * 2006-04-13 2010-01-28 Actelion Pharmaceeuticals Ltd. Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
DE102008030207A1 (de) 2008-06-25 2009-12-31 Bayer Schering Pharma Aktiengesellschaft Substituierte 7-Sulfanylmethyl-, 7-Sulfinylmethyl- und 7-Sulfonylmethyl-Indole und ihre Verwendung
DE102008030206A1 (de) 2008-06-25 2009-12-31 Bayer Schering Pharma Aktiengesellschaft 3-Cyanoalky- und 3-Hydroxyalkyl-Indole und ihre Verwendung
WO2018064465A1 (en) 2016-09-29 2018-04-05 The Regents Of The University Of California Compounds for increasing neural plasticity
CN106674065A (zh) * 2016-12-07 2017-05-17 贵州大学 一种5‑卤代‑2‑烷氧基‑4‑甲苯磺酰氯制备方法
GB201817038D0 (en) * 2018-10-19 2018-12-05 Inflazome Ltd Novel processes
EP3931189A4 (en) 2019-02-27 2022-11-30 The Regents Of The University Of California Azepino-indoles and other heterocycles for treating brain disorders
CA3239565A1 (en) 2021-12-15 2023-06-22 Delix Therapeutics, Inc. Phenoxy and benzyloxy substituted psychoplastogens and uses thereof
CN117263832A (zh) * 2023-08-18 2023-12-22 辽宁龙田化工科技有限公司 一种2-氯-4-甲磺酰基苯甲酸合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE637355A (cs) * 1962-09-14
DE1950346B2 (de) * 1968-10-08 1973-06-28 Sumitomo Chemical Co 2-indolylessigsaeureverbindungen und diese verbindungen enthaltende arzneipraeparate
US4397079A (en) * 1981-03-30 1983-08-09 International Business Machines Corp. Process for improving the yield of integrated devices including Schottky barrier diodes
US5245046A (en) * 1988-11-14 1993-09-14 The Upjohn Company α-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents
DE69118388T2 (de) 1990-09-10 1996-11-14 Rhone Poulenc Rorer Int Substituierte bizyklische arylderivate mit selektiver leukotrien b4 antagonistischer wirkung
ZA939516B (en) * 1992-12-22 1994-06-06 Smithkline Beecham Corp Endothelin receptor antagonists
PT617001E (pt) * 1993-03-19 2000-06-30 Merck & Co Inc Derivados do acido fenoxifenilacetico
GB9317096D0 (en) * 1993-08-17 1993-09-29 Pfizer Ltd Indoles

Also Published As

Publication number Publication date
HUP9901245A3 (en) 2002-01-28
DZ2227A1 (fr) 2002-12-25
ATE263151T1 (de) 2004-04-15
HUP9901245A2 (hu) 1999-08-30
TW491838B (en) 2002-06-21
EA199800908A1 (ru) 1999-06-24
IS4838A (is) 1998-08-28
NO312547B1 (no) 2002-05-27
BG102873A (en) 1999-11-30
CO4650036A1 (es) 1998-09-03
HN1997000058A (es) 1997-06-26
CZ292928B6 (cs) 2004-01-14
TR199802269T2 (xx) 2001-12-21
EP0901470A1 (en) 1999-03-17
AR007030A1 (es) 1999-10-13
DE69728392T2 (de) 2005-01-13
EA001471B1 (ru) 2001-04-23
PL329725A1 (en) 1999-04-12
US6017945A (en) 2000-01-25
UY24546A1 (es) 2000-09-29
US6306852B1 (en) 2001-10-23
ES2218675T3 (es) 2004-11-16
AU2697897A (en) 1997-12-05
ZA973963B (en) 1998-11-09
DE69728392D1 (de) 2004-05-06
CA2253876A1 (en) 1997-11-20
BR9709072A (pt) 1999-08-03
ID16878A (id) 1997-11-20
KR100331217B1 (ko) 2002-05-09
CN1124262C (zh) 2003-10-15
SK150398A3 (en) 1999-03-12
NZ332640A (en) 2001-03-30
JPH11508285A (ja) 1999-07-21
US20010014677A1 (en) 2001-08-16
NO985225D0 (no) 1998-11-09
IL125903A0 (en) 1999-04-11
CN1216531A (zh) 1999-05-12
US6384070B2 (en) 2002-05-07
HK1019149A1 (en) 2000-01-14
OA10896A (en) 2001-10-11
US6136843A (en) 2000-10-24
AP9700982A0 (en) 1997-07-31
AP830A (en) 2000-05-03
DK0901470T3 (da) 2004-07-12
TNSN97078A1 (fr) 2005-03-15
UA50767C2 (uk) 2002-11-15
PT901470E (pt) 2004-07-30
GB9609641D0 (en) 1996-07-10
MA26428A1 (fr) 2004-12-20
EP0901470B1 (en) 2004-03-31
PE65098A1 (es) 1998-10-29
IS1856B (is) 2003-02-21
NO985225L (no) 1998-11-09
AU717849B2 (en) 2000-04-06
HRP970249A2 (en) 1998-06-30
JP3245179B2 (ja) 2002-01-07
WO1997043260A1 (en) 1997-11-20
CZ358298A3 (cs) 1999-08-11
HRP970249B1 (en) 2003-06-30
KR20000010879A (ko) 2000-02-25

Similar Documents

Publication Publication Date Title
IL125903A0 (en) Indole derivatives useful as endothelin receptor antagonists
AU4746297A (en) Vitronectin receptor antagonists
HU9601529D0 (en) Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists
GB9718913D0 (en) Substituted oxindole derivatives
EP0912175A4 (en) FIBRINOGENIC RECEPTOR ANTAGONISTS
GR3035075T3 (en) Indole derivatives as 5-ht receptor antagonist
IL123581A0 (en) Pyrimidine derivatives as 5HT2c- receptor antagonists
EP0885205A4 (en) Fibrinogen Receptor Antagonists
EP0885213A4 (en) FIBRINOGEN RECEPTOR ANTAGONISTS
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
HUP9903480A3 (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
AU1296899A (en) Phenyl-alkyl-imidazoles as h3 receptor antagonists
IL127417A0 (en) Indoline derivatives useful as 5-HT-2C receptor antagonists
AU8871898A (en) Phenylindole derivatives as 5-ht2a receptor antagonists
AU3611099A (en) Oxindole derivatives used as neurokinin receptor antagonists
AU4980999A (en) A3 adenosine receptor antagonists
AU1150999A (en) Indole derivative useful as endothelin receptor antagonist
AU6826498A (en) Endotholin receptor antagonists
AU2943899A (en) Indole derivatives as 5-ht2a receptor antagonists
SI0912556T1 (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
HK1019747A (en) Indoline derivatives useful as 5-ht-2c receptor antagonists
HK1020955A (en) Endothelin receptor antagonists
HK1023780A (en) G protein-coupled receptor antagonists
GB9811283D0 (en) Vironectin receptor antagonists
IL108842A0 (en) Benzylimidazopyridine derivatives as angiotensin II receptor antagonists